These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 946847)

  • 1. Thrombocytopenia associated with long-term levodopa therapy.
    Wanamaker WM; Wanamaker SJ; Celesia GG; Koeller AA
    JAMA; 1976 May; 235(20):2217-9. PubMed ID: 946847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of two malignant melanomas during administration of levodopa.
    Przybilla B; Schwab U; Landthaler M; Braun-Falco O
    Acta Derm Venereol; 1985; 65(6):556-7. PubMed ID: 2420127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of home-made levodopa in 43 cases of paralysis agitans.
    Liu D; Jiang Y
    Chin Med J (Engl); 1979 Nov; 92(11):807-10. PubMed ID: 116825
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion.
    Meiler B; Andrich J; Müller T
    Mov Disord; 2008 Jan; 23(1):145-6. PubMed ID: 17987653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Black cartilage after therapy with levodopa and methyldopa.
    Rausing A; Rosén U
    Arch Pathol Lab Med; 1994 May; 118(5):531-5. PubMed ID: 8192560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on long-term levodopa therapy in Parkinson's disease].
    Mizuno Y
    Nihon Naika Gakkai Zasshi; 1982 Nov; 71(11):1553-9. PubMed ID: 7166671
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.
    Barbeau A
    Can Med Assoc J; 1975 Jun; 112(12):1379-80. PubMed ID: 1139474
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
    Dufresne JJ
    Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
    [No Abstract]   [Full Text] [Related]  

  • 10. Appraisal of long-term levodopa treatment of parkinsonism with special reference to therapy limiting factors.
    Presthus J; Holmsen R
    Acta Neurol Scand; 1974; 50(6):774-90. PubMed ID: 4440452
    [No Abstract]   [Full Text] [Related]  

  • 11. [Multivariate analysis of the problems of long-term levodopa therapy in Parkinson's disease].
    Nakamura Y; Yoshinaga J; Endo S; Hikiji A
    Rinsho Shinkeigaku; 1997 Jun; 37(6):469-75. PubMed ID: 9366172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Ascorbic acid in levodopa therapy.
    Sacks W; Simpson GM
    Lancet; 1975 Mar; 1(7905):527. PubMed ID: 47001
    [No Abstract]   [Full Text] [Related]  

  • 13. Levodopa in the treatment of Parkinson's disease.
    Schapira AH; Emre M; Jenner P; Poewe W
    Eur J Neurol; 2009 Sep; 16(9):982-9. PubMed ID: 19538218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous infusion of L-dopa: current prospective therapies].
    Peppe A; De Angelis D; Tolli VS; Rizzo PA; Scoppetta C
    Riv Neurol; 1991; 61(5):197-200. PubMed ID: 1808680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
    Montastruc JL; Celsis P; Agniel A; Demonet JF; Doyon B; Puel M; Marc-Vergnes JP; Rascol A
    Mov Disord; 1987; 2(4):279-89. PubMed ID: 3509776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
    Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A year of treatment with carbidopa and levodopa in Parkinsonian patients].
    Martínez-Lage JM; Marti-Massó JF; Delgado G; Carreray N; Del Amo F
    Rev Clin Esp; 1974 Sep; 134(6):535-42. PubMed ID: 4450036
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombocytopenia associated with levodopa treatment.
    Giner V; Rueda D; Salvador A; Hernández JC; Esteban MJ; Redón J
    Arch Intern Med; 2003 Mar; 163(6):735-6. PubMed ID: 12639208
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism.
    Sage JI; Trooskin S; Sonsalla PK; Heikkila R; Duvoisin RC
    Ann Neurol; 1988 Jul; 24(1):87-9. PubMed ID: 3415201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.